Evidence map›Paper›PMID 39104865›Full record

ArticleJournal of pharmaceutical analysis2024

A novel fluorescent labeling compound for GluN2A containing

Alexander Dombovski, Ruben Steigerwald, Nadine Ritter, Paul Disse, Gunnar Goerges, Jana Osthues, Isabel Aymanns, Carina Dilkaute, Julian Schreiber, Martina Düfer and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of pharmaceutical analysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Alexander DombovskiUniversity of Münster, Institute of Pharmaceutical and Medicinal Chemistry, Pharmacampus, 48149, Münster, Germany.
Ruben SteigerwaldUniversity of Münster, Institute of Pharmaceutical and Medicinal Chemistry, Pharmacampus, 48149, Münster, Germany.
Nadine RitterUniversity of Münster, GRK 2515, Chemical Biology of Ion Channels (Chembion), 48149, Münster, Germany.
Paul DisseUniversity of Münster, GRK 2515, Chemical Biology of Ion Channels (Chembion), 48149, Münster, Germany.
Gunnar GoergesUniversity of Münster, Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany.
Jana OsthuesUniversity of Münster, Institute of Pharmaceutical and Medicinal Chemistry, Pharmacampus, 48149, Münster, Germany.
Isabel AymannsUniversity of Münster, Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany.
Carina DilkauteUniversity of Münster, Institute of Pharmaceutical and Medicinal Chemistry, Pharmacampus, 48149, Münster, Germany.
Julian SchreiberUniversity of Münster, Institute of Pharmaceutical and Medicinal Chemistry, Pharmacampus, 48149, Münster, Germany.
Martina DüferUniversity of Münster, Institute of Pharmaceutical and Medicinal Chemistry, Pharmacampus, 48149, Münster, Germany.
Guiscard SeebohmUniversity of Münster, GRK 2515, Chemical Biology of Ion Channels (Chembion), 48149, Münster, Germany.
Bernhard WünschUniversity of Münster, Institute of Pharmaceutical and Medicinal Chemistry, Pharmacampus, 48149, Münster, Germany.
Joachim JoseUniversity of Münster, Institute of Pharmaceutical and Medicinal Chemistry, Pharmacampus, 48149, Münster, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Image 1.

Identifiers

PMID39104865
PMCPMC11298907

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.